(2E,4R)-5-[1,1′-biphenyl]-4-yl-4-[[(1,1-dimethylethoxy)carbonyl]amino]-2-methyl-2-Pentenoic acid
![(R,E)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpent-2-enoic acid](https://www.tianmingpharm.com/wp-content/uploads/2024/08/1012341-48-8.png)
CAS:1012341-48-8
Chemical Formula:C23H27NO4
MW:381.46
Availability: R&D; Commercialization
⬤ CAS No. 1012341-48-8
⬤ Packaging type：20kg barrel；5kg barrel；1kg bag；500g bag ; Customized Packaging
| English Name | (R,E)-4-Boc-amino-2-methyl-5-(biphenyl-4-yl)-2-pentenoic acid LCZ696 intermediate |
| CAS No. | 1012341-48-8 |
| Chemical Formula | C23H27NO4 |
| Molecular Weight | 381.46 |
| Related Categories | LCZ696 intermediate; pharmaceutical intermediate; impurity reference substance; chemical reagent; LCZ696; intermediate; intermediates |
| Mol | 1012341-48-8.mol |
| Melting point | 188 – 191°C |
| Boiling point | 595.6±50.0 °C(Predicted) |
| Density | 1.132±0.06 g/cm3(Predicted) |
| Vapor pressure | 8.4-839.931Pa at 20℃ |
| Storage conditions | -Sealed in dry,Room Temperature |
| Solubility | Soluble in DMSO (a little), methanol (a little) |
| Acidity coefficient (pKa) | 4.67±0.19(Predicted) |
| Form | Solid |
| Color | White to off-white |
| LogP | 2.2-3.6 at 25℃ and pH2.5-7 |
| Personal protection | Wear protective equipment: Wear appropriate protective clothing, chemical protective glasses, chemical protective gloves and protective shoes during operation. If dust may be generated, wear a dust mask. Avoid skin contact: The product may irritate the skin and direct contact with the skin should be avoided as much as possible. If contact occurs accidentally, rinse immediately with plenty of water and seek medical help. Avoid eye contact: Prevent the product from splashing into the eyes. If it happens, rinse the eyes immediately with plenty of water and seek medical help. |
| Environmental Control | Good ventilation: Maintain good ventilation conditions in the operating area to reduce the concentration in the air. Prevent leakage: Measures should be taken to prevent product leakage, such as using sealed containers and leakage emergency treatment equipment. |
| Introduction | (R,E)-4-Boc-amino-2-methyl-5-(biphenyl-4-yl)-2-pentenoic acid LCZ696 intermediate is a key intermediate in the synthesis of various drugs, especially in the synthesis of LCZ696 (an angiotensin receptor-neprilysin inhibitor used to treat heart failure). This compound is widely used as an important intermediate. |
| Uses | An intermediate used in the synthesis of certain drugs, such as LCZ696 (also known as sacubitril-valsartan). LCZ696 is a combination preparation consisting of the enkephalinase inhibitor sacubitril and the angiotensin receptor antagonist valsartan, mainly used to treat cardiovascular diseases such as heart failure and hypertension. |
Exceptional Product Quality
“We have been sourcing pharmaceuticals from Tianming Pharmaceutical for several years now, and their product quality has consistently exceeded our expectations. Each batch undergoes rigorous testing, ensuring we receive only the highest quality products. This reliability has significantly contributed to our trust and satisfaction with their services. Highly recommended!”
June 15, 2023
Outstanding Technical Guidance
“The technical guidance provided by Tianming Pharmaceutical’s team has been invaluable to our research and development projects. Their experts are knowledgeable, responsive, and always willing to assist with detailed explanations and support. Their guidance has enabled us to optimize our processes and achieve remarkable results. We couldn’t ask for a better partner.”
June 15, 2023
Superior Service Experience
“Our experience with Tianming Pharmaceutical has been nothing short of excellent. Their customer service team is exceptionally responsive and dedicated to meeting our needs. From initial consultation to after-sales support, they have provided seamless, professional service. Their commitment to customer satisfaction is truly commendable.”
June 15, 2023
Precise Product Specifications
“Tianming Pharmaceutical has impressed us with their adherence to precise product specifications. Each order is meticulously packaged and delivered exactly as requested, ensuring that we receive products that perfectly meet our requirements. Their attention to detail and commitment to accuracy have made them a trusted supplier for our business.”
June 15, 2023
This article breaks down the 4 most costly mistakes — including incomplete documentation and ignored scalability — with verified industry data and real cases.
End-to-end supply chain for anti-diabetic intermediates. Covering DPP-4, SGLT-2 inhibitors & GPR40 agonists. Stable, compliant, scalable.
Drawing from on-the-ground experience in China’s top pharma clusters, this guide cuts through the jargon to reveal when to partner for complex innovation and when to buy from the workhorses of mature production.
Leading provider of high-quality APIs and intermediates. Contact us for innovative solutions and expert support.
